Third Wave to Develop Invader with Japanese Laboratory | GenomeWeb

NEW YORK, Jan 11 – Third Wave Technologies has signed a development and commercialization agreement with BML, one of the largest clinical reference laboratories in Japan, to use its Invader DNA and RNA mutation detection system for pharmacogenomic and clinical testing, the companies announced Thursday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.